Profound Medical Corp. - Common Shares (PROF) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Common Shares
Symbol
PROF on Nasdaq
Shares outstanding
29,881,634
Price per share
$7.87
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
11,063,194
Total reported value
$54,283,775
% of total 13F portfolios
0%
Share change
-1,419,146
Value change
-$7,406,922
Number of holders
43
Price from insider filings
$7.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Profound Medical Corp. - Common Shares (PROF) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GAGNON SECURITIES LLC 11% $15,796,627 3,346,743 Neil Gagnon 31 Dec 2024

As of 30 Sep 2025, 43 institutional investors reported holding 11,063,194 shares of Profound Medical Corp. - Common Shares (PROF). This represents 37% of the company’s total 29,881,634 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Profound Medical Corp. - Common Shares (PROF) together control 37% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIL Ltd 6.3% 1,885,000 0% 0.01% $9,387,305
GAGNON SECURITIES LLC 5.8% 1,733,040 -0.96% 1.7% $8,474,566
LETKO, BROSSEAU & ASSOCIATES INC 3.3% 986,250 -18% 0.08% $4,824,097
Gagnon Advisors, LLC 3% 896,671 0% 2.7% $4,384,721
ROYCE & ASSOCIATES LP 2.9% 859,906 +12% 0.04% $4,201,596
Rosalind Advisors, Inc. 2.3% 692,185 0% 1.2% $3,384,784
Timelo Investment Management Inc. 2% 603,539 -28% 4.9% $2,951,306
MMCAP International Inc. SPC 1.7% 500,859 +2% 0.28% $2,449,201
ROYAL BANK OF CANADA 1.6% 485,920 +5.7% 0% $2,377,000
Ring Mountain Capital, LLC 1.3% 394,864 +10% 1.1% $1,931,000
ARDSLEY ADVISORY PARTNERS LP 1.1% 330,000 0% 0.25% $1,613,700
First Eagle Investment Management, LLC 0.98% 291,391 +139% 0% $1,451,127
THOMPSON DAVIS & CO., INC. 0.7% 208,720 -0.84% 0.63% $1,020,641
FORMULA GROWTH LTD 0.68% 202,918 -16% 0.35% $992,269
BANK OF AMERICA CORP /DE/ 0.67% 200,160 +14% 0% $978,783
Bleichroeder LP 0.61% 183,333 0% 0.17% $896,498
NATIONAL BANK OF CANADA /FI/ 0.58% 172,883 +7.3% 0% $844,749
RAYMOND JAMES FINANCIAL INC 0.51% 151,511 -84% 0% $740,889
TD Waterhouse Canada Inc. 0.25% 75,293 +34% 0% $356,063
TRUIST FINANCIAL CORP 0.17% 50,000 0% 0% $244,500
Northwest & Ethical Investments L.P. 0.13% 38,200 -17% 0% $186,671
MTM Investment Management, LLC 0.06% 17,975 0% 0.03% $87,898
Kovitz Investment Group Partners, LLC 0.06% 16,722 0% 0% $81,735
GEODE CAPITAL MANAGEMENT, LLC 0.05% 14,049 0% 0% $69,964
GOLDMAN SACHS GROUP INC 0.04% 11,940 +3% 0% $58,387

Institutional Holders of Profound Medical Corp. - Common Shares (PROF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 216,735 $1,705,704 +$63,078 $7.87 1
2025 Q3 11,063,194 $54,283,775 -$7,406,922 $4.89 43
2025 Q2 12,482,340 $73,650,616 -$2,042,016 $5.90 44
2025 Q1 12,825,851 $73,303,109 -$7,205,786 $5.82 48
2024 Q4 13,763,555 $102,960,287 +$30,141,003 $7.51 51
2024 Q3 9,406,781 $74,869,184 -$1,117,706 $7.96 42
2024 Q2 9,510,240 $80,047,787 -$132,453 $8.39 37
2024 Q1 9,500,142 $80,114,995 +$2,238,848 $8.53 39
2023 Q4 9,251,176 $77,759,535 +$10,244,275 $8.49 45
2023 Q3 7,489,374 $75,450,155 -$1,487,679 $10.20 30
2023 Q2 7,634,234 $98,724,050 -$1,129,044 $13.01 29
2023 Q1 7,726,121 $71,704,219 -$6,964,776 $9.29 30
2022 Q4 8,472,949 $91,726,796 +$3,083,523 $10.89 33
2022 Q3 8,745,198 $35,381,959 -$177,655 $4.04 30
2022 Q2 8,675,590 $63,032,248 -$3,670,846 $7.29 34
2022 Q1 9,402,835 $84,635,691 -$3,611,432 $9.00 41
2021 Q4 9,774,988 $109,777,858 -$2,915,423 $11.24 44
2021 Q3 8,722,358 $127,589,352 -$1,309,423 $14.64 46
2021 Q2 8,722,951 $142,593,346 -$126,994 $16.36 46
2021 Q1 8,673,835 $174,440,609 +$8,178,699 $20.14 52
2020 Q4 8,182,487 $168,377,436 +$26,332,305 $20.56 53
2020 Q3 7,009,150 $123,510,789 +$42,298,243 $17.64 44
2020 Q2 4,612,581 $78,146,000 -$131,017 $16.94 33
2020 Q1 4,764,927 $46,182,000 +$27,289,444 $9.74 31
2019 Q4 1,948,600 $21,824,000 +$21,824,000 $10.98 16